{"entity":{"type":"insider","cik":"0001612396","url":"/insider/0001612396","json_url":"/insider/0001612396.json","name":"Dallas Matthew D","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2015-01-08","last":"2017-01-04","span_basis":"filed_date"},"name_variants":[{"name":"Dallas Matthew D","source":"filing","n_filings":4,"first_seen":"2015-01-08","last_seen":"2017-01-04"}],"transactions":[{"id":4105122,"accession":"0000911916-17-000026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000911916-17-000026","line_url":"/filing/0000911916-17-000026#line-1","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001612396","owner_name":"Dallas Matthew D","owner_url":"/insider/0001612396","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1473.0,"shares_display":"1,473","price_per_share":36.25,"price_display":"36.25","price_state":"stated","total_value":53396.25,"total_display":"53,396.25","shares_owned_after":40128.0,"shares_owned_after_display":"40,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-03","filed_date":"2017-01-04","scope":"insider"},{"id":3200838,"accession":"0000911916-16-000693","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000911916-16-000693","line_url":"/filing/0000911916-16-000693#line-1","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":"0001612396","owner_name":"Dallas Matthew D","owner_url":"/insider/0001612396","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1473.0,"shares_display":"1,473","price_per_share":35.1671,"price_display":"35.17","price_state":"stated","total_value":51801.1383,"total_display":"51,801.14","shares_owned_after":41601.0,"shares_owned_after_display":"41,601","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-01","filed_date":"2016-12-01","scope":"insider"},{"id":8783033,"accession":"0001209191-15-005096","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-005096","line_url":"/filing/0001209191-15-005096#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001612396","owner_name":"Dallas Matthew D","owner_url":"/insider/0001612396","role":"Officer (VP, Finance)","officer_title":"VP, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3075.0,"shares_display":"3,075","price_per_share":0.817,"price_display":"0.82","price_state":"stated","total_value":2512.275,"total_display":"2,512.28","shares_owned_after":14506.0,"shares_owned_after_display":"14,506","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-16","filed_date":"2015-01-20","scope":"insider"},{"id":8824424,"accession":"0001209191-15-003154","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-003154","line_url":"/filing/0001209191-15-003154#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001612396","owner_name":"Dallas Matthew D","owner_url":"/insider/0001612396","role":"Officer (VP, Finance)","officer_title":"VP, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":519.0,"shares_display":"519","price_per_share":0.7998,"price_display":"0.80","price_state":"stated","total_value":415.0962,"total_display":"415.10","shares_owned_after":17581.0,"shares_owned_after_display":"17,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-07","filed_date":"2015-01-08","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001348649","name":"CoLucid Pharmaceuticals, Inc.","url":"/issuer/0001348649","role":"Officer (Chief Financial Officer)","n_filings":2,"first_seen":"2016-12-01","last_seen":"2017-01-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001325879","name":"AVEO PHARMACEUTICALS INC","url":"/issuer/0001325879","role":"Officer (VP, Finance)","n_filings":2,"first_seen":"2015-01-08","last_seen":"2015-01-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001612396","retrieved_at":"2026-08-22T01:43:21+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}